Washington University School of Medicine: Carcinoma trials

The registry lists 20 Carcinoma studies with Washington University School of Medicine as lead sponsor. 0 are open to participants now and 11 have results posted.

Phase 1 7Phase 2 10No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CTTerminatedNCT04685798Not applicableResults posted
• Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)TerminatedNCT04267120Phase 2Results posted
• Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based ChemotherapyTerminatedNCT03655444Phase 1/2Results posted
• MK-3475 Immunotherapy in Endometrial CarcinomaCompletedNCT02630823Phase 1Results posted
• Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)CompletedNCT02573493Phase 2Results posted
• The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting BeadTerminatedNCT01259024Not applicableResults posted
• Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal CarcinomaCompletedNCT00868192Phase 2Results posted
• Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck CancerCompletedNCT00736944Phase 2Results posted
• Genotype-directed Neoadjuvant Chemoradiation for Rectal CarcinomaCompletedNCT00682786Phase 2Results posted
• Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck CancerCompletedNCT00671437Phase 2Results posted
• A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal CarcinomatosisTerminatedNCT00352755Phase 2Results posted
• Tazemetostat and Pembrolizumab in Patients With Pembrolizumab- or Nivolumab-Resistant, Recurrent or Metastatic Head and Neck Squamous-Cell CarcinomaTerminatedNCT04624113Phase 1
• PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell CarcinomaWithdrawnNCT03598816Phase 2
• How Microbes and Metabolism May Predict Skin Cancer Immunotherapy OutcomesTerminatedNCT03370861
• Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid TumorsWithdrawnNCT02537561Phase 1
• Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT01716416Phase 1
• Radiofrequency Ablation in Treating Patients With Liver Cancer (Hepatocellular Carcinoma)WithdrawnNCT01669668Phase 2
• Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic CholangiocarcinomaCompletedNCT01668134Phase 1
• Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal CancerActive, not recruitingNCT01061515Phase 1
• Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver CancerCompletedNCT00081094Not applicable